135 related articles for article (PubMed ID: 37079290)
1. Biomarker-based prediction of fatal and non-fatal cardiovascular outcomes in individuals with diabetes mellitus.
Haller PM; Goßling A; Magnussen C; Brenner H; Schöttker B; Iacoviello L; Costanzo S; Kee F; Koenig W; Linneberg A; Sujana C; Thorand B; Salomaa V; Niiranen TJ; Söderberg S; Völzke H; Dörr M; Sans S; Padró T; Felix SB; Nauck M; Petersmann A; Palmieri L; Donfrancesco C; De Ponti R; Veronesi G; Ferrario MM; Kuulasmaa K; Zeller T; Ojeda FM; Blankenberg S; Westermann D;
Eur J Prev Cardiol; 2023 Sep; 30(12):1218-1226. PubMed ID: 37079290
[TBL] [Abstract][Full Text] [Related]
2. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.
Kistorp C; Raymond I; Pedersen F; Gustafsson F; Faber J; Hildebrandt P
JAMA; 2005 Apr; 293(13):1609-16. PubMed ID: 15811980
[TBL] [Abstract][Full Text] [Related]
3. The Interplay between Fasting Glucose, Echocardiography, and Biomarkers: Pathophysiological Considerations and Prognostic Implications.
Pareek M
Dan Med J; 2017 Sep; 64(9):. PubMed ID: 28874244
[TBL] [Abstract][Full Text] [Related]
4. Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein but not cystatin C predict cardiovascular events in male patients with peripheral artery disease independently of ambulatory pulse pressure.
Skoglund PH; Arpegård J; Ostergren J; Svensson P
Am J Hypertens; 2014 Mar; 27(3):363-71. PubMed ID: 24470529
[TBL] [Abstract][Full Text] [Related]
5. High-Sensitivity Cardiac Troponin-T and N-Terminal Prohormone of B-Type Natriuretic Peptide in Relation to Cardiovascular Outcomes in Type 1 Diabetes.
Costacou T; Saenger AK; Orchard TJ
Diabetes Care; 2020 Sep; 43(9):2199-2207. PubMed ID: 32616616
[TBL] [Abstract][Full Text] [Related]
6. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
Goei D; Hoeks SE; Boersma E; Winkel TA; Dunkelgrun M; Flu WJ; Schouten O; Bax JJ; Poldermans D
Coron Artery Dis; 2009 May; 20(3):219-24. PubMed ID: 19322079
[TBL] [Abstract][Full Text] [Related]
7. The relative and combined ability of high-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide to predict cardiovascular events and death in patients with type 2 diabetes.
Hillis GS; Welsh P; Chalmers J; Perkovic V; Chow CK; Li Q; Jun M; Neal B; Zoungas S; Poulter N; Mancia G; Williams B; Sattar N; Woodward M
Diabetes Care; 2014; 37(1):295-303. PubMed ID: 24089534
[TBL] [Abstract][Full Text] [Related]
8. Multiple Cardiac Biomarkers to Improve Prediction of Cardiovascular Events: Findings from the Generation Scotland Scottish Family Health Study.
Welsh P; Kimenai DM; Shah ASV; Gadd DA; Marioni RE; Woodward M; Sudlow CLM; Campbell A; Cleland JGF; Pellicori P; Hayward C; Mills NL; Sattar N
Clin Chem; 2024 Feb; 70(2):403-413. PubMed ID: 38069915
[TBL] [Abstract][Full Text] [Related]
9. N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population.
Olsen MH; Hansen TW; Christensen MK; Gustafsson F; Rasmussen S; Wachtell K; Ibsen H; Torp-Pedersen C; Hildebrandt PR
Eur Heart J; 2007 Jun; 28(11):1374-81. PubMed ID: 17242007
[TBL] [Abstract][Full Text] [Related]
10. N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease.
Bibbins-Domingo K; Gupta R; Na B; Wu AH; Schiller NB; Whooley MA
JAMA; 2007 Jan; 297(2):169-76. PubMed ID: 17213400
[TBL] [Abstract][Full Text] [Related]
11. Targeted multiple biomarker approach in predicting cardiovascular events in patients with diabetes.
Resl M; Clodi M; Vila G; Luger A; Neuhold S; Wurm R; Adlbrecht C; Strunk G; Fritzer-Szekeres M; Prager R; Pacher R; Hülsmann M
Heart; 2016 Dec; 102(24):1963-1968. PubMed ID: 27456261
[TBL] [Abstract][Full Text] [Related]
12. Single and multiple cardiovascular biomarkers in subjects without a previous cardiovascular event.
Pareek M; Bhatt DL; Vaduganathan M; Biering-Sørensen T; Qamar A; Diederichsen AC; Møller JE; Hindersson P; Leósdóttir M; Magnusson M; Nilsson PM; Olsen MH
Eur J Prev Cardiol; 2017 Oct; 24(15):1648-1659. PubMed ID: 28644092
[TBL] [Abstract][Full Text] [Related]
13. Assessment of multiple cardiac biomarkers in non-ST-segment elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 trial.
Scirica BM; Sabatine MS; Jarolim P; Murphy SA; de Lemos JL; Braunwald E; Morrow DA
Eur Heart J; 2011 Mar; 32(6):697-705. PubMed ID: 21183500
[TBL] [Abstract][Full Text] [Related]
14. Diabetes status-related differences in risk factors and mediators of heart failure in the general population: results from the MORGAM/BiomarCaRE consortium.
Vuori MA; Reinikainen J; Söderberg S; Bergdahl E; Jousilahti P; Tunstall-Pedoe H; Zeller T; Westermann D; Sans S; Linneberg A; Iacoviello L; Costanzo S; Salomaa V; Blankenberg S; Kuulasmaa K; Niiranen TJ
Cardiovasc Diabetol; 2021 Sep; 20(1):195. PubMed ID: 34583686
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of multiple emerging biomarkers in cardiovascular risk prediction in patients with stable cardiovascular disease.
Ahluwalia N; Blacher J; Szabo de Edelenyi F; Faure P; Julia C; Hercberg S; Galan P
Atherosclerosis; 2013 Jun; 228(2):478-84. PubMed ID: 23582589
[TBL] [Abstract][Full Text] [Related]
16. Increased cardiac troponin I as measured by a high-sensitivity assay is associated with high odds of cardiovascular death: the Minnesota Heart Survey.
Apple FS; Steffen LM; Pearce LA; Murakami MM; Luepker RV
Clin Chem; 2012 May; 58(5):930-5. PubMed ID: 22431895
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers to predict recurrent cardiovascular disease: the Heart and Soul Study.
Shlipak MG; Ix JH; Bibbins-Domingo K; Lin F; Whooley MA
Am J Med; 2008 Jan; 121(1):50-7. PubMed ID: 18187073
[TBL] [Abstract][Full Text] [Related]
18. Subclinical Cardiovascular Disease in US Adults With and Without Diabetes.
Fang M; Wang D; Tang O; McEvoy JW; Echouffo-Tcheugui JB; Christenson RH; Selvin E
J Am Heart Assoc; 2023 Jun; 12(11):e029083. PubMed ID: 37254959
[TBL] [Abstract][Full Text] [Related]
19. Circulating biomarkers for long-term cardiovascular risk stratification in apparently healthy individuals from the MONICA 10 cohort.
Frary CE; Blicher MK; Olesen TB; Stidsen JV; Greve SV; Vishram-Nielsen JK; Rasmussen SL; Olsen MH; Pareek M
Eur J Prev Cardiol; 2020 Apr; 27(6):570-578. PubMed ID: 31718257
[TBL] [Abstract][Full Text] [Related]
20. N-terminal brain natriuretic peptide predicted cardiovascular events stronger than high-sensitivity C-reactive protein in hypertension: a LIFE substudy.
Olsen MH; Wachtell K; Nielsen OW; Hall C; Wergeland R; Ibsen H; Kjeldsen SE; Devereux RB; Dahlöf B; Hildebrandt PR
J Hypertens; 2006 Aug; 24(8):1531-9. PubMed ID: 16877955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
